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Abstract
Background:  Periodic catatonia is a familial subtype of schizophrenia characterized by
hyperkinetic and akinetic episodes, followed by a catatonic residual syndrome. The phenotype has
been evaluated in two independent genome-wide linkage scans with evidence for a major locus on
chromosome 15q15, and a second independent locus on chromosome 22qtel.
Methods: In the positional and brain-expressed candidate genes KIAA0767 and KIAA1646, we
searched for variants in the complete exons and adjacent splice-junctions as well as in parts of the
5'- and 3'-untranslated regions by means of a systematic mutation screening in individuals from
chromosome 22q-linked pedigrees.
Results: The mutation scan revealed 24 single nucleotide polymorphisms, among them two rare
codon variants (KIAA0767: S159I; KIAA1646: V338G). However, both were neither found
segregating with the disease in the respective pedigree nor found at a significant frequency in a case-
control association sample.
Conclusion: Starting from linkage signals at chromosome22qtel in periodic catatonia, we screened
two positional brain-expressed candidate genes for genetic variation. Our study excludes genetic
variations in the coding and putative promoter regions of KIAA0767 and KIAA1646 as causative
factors for periodic catatonia.
Background
The phenotype of periodic catatonia is characterized by
hyperkinetic and akinetic episodes with parakinetic
movements in a bipolar course, accompanied by
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delusional or hallucinatory symptoms, and followed by
residual states with psychomotor features [1,2]. The esti-
mated lifetime prevalence of periodic catatonia is ~0.001
in the general population. Evidence for significant linkage
to chromosome 15q15 was obtained and replicated in
two independent genome-wide linkage scans [3,4].
Mainly supported by a single four-generation pedigree, a
second locus was identified on chromosome 22q with a
maximum multipoint LOD score of 2.59 (θ = 0.0) under
an autosomal dominant model at marker D22S1169, and
with a heterogeneity Zmax of 1.57 with an estimated 38%
of families linked [3]. Preliminary findings had suggested
a link between MLC1 and catatonia via a putative domi-
nantly acting missense mutation cosegregating in a large
pedigree, but further analyses have excluded sequence var-
iants of MLC1 as causing chromosome 22q-linked catato-
nia. MLC1 is the disease causing gene for autosomal
recessively inherited megalencephalic leukoencephalopa-
thy with subcortical cysts [5-7]. A systematic mutation
screening in 140 index cases with periodic catatonia and
five cases with MLC detected a high degree of sequence
diversity of MLC1 with evidence for further allelic hetero-
geneity of MLC1 mutations in MLC, but unfortunately the
study failed to validate an association of schizophrenia to
genetic variants of MLC1. Among periodic catatonia index
cases, the mutation scan revealed 15 different single
nucleotide polymorphisms, among them three coding
variants: two of them were observed in controls at a signif-
icant frequency, and the L309M variant, that was previ-
ously supposed to be the causative factor for chromosome
22qtel linked periodic catatonia, was found non-segregat-
ing in a further multiplex pedigree [6]. In addition, MLC1
is a 377 amino acid protein with preferential expression in
the brain and peripheral white blood cells. In the brain,
MLC1 is specifically expressed in distal astroglial proc-
esses in perivascular, subependymal, and subpial regions.
Although MLC1 shares low homology with human volt-
age-gated potassium channels, addressing the membrane
topology and cellular localization of MLC1 supports the
possible transport function of MLC1 for a specific, yet
unknown substrate [8,9]. Thus, mutations in MLC1 are
causative for MLC, but can be excluded as a susceptibility
factor in schizophrenia. Reports of other groups also
failed to support an aetiological relevance of this gene in
schizophrenia [10-12] and more importantly, these stud-
ies [6,12] rule out that spongiform leukodystrophies and
subtypes of schizophrenia are allelic disorders.
Under the assumption of disease heterogeneity and allelic
heterogeneity [13], we screened in a systematic approach
the positional candidate genes KIAA1646 and KIAA0767,
located between 45.34–45.45 Mb [14], for genetic varia-
tion. Human KIAA0767 is a mitochondrial protein of 578
amino acids (aa) with high expression in adult brain and
strong pro-apoptotic effect [15,16]. KIAA1646 is a cyto-
plasmatic and membrane-associated ceramide kinase
(CERK) of 537 amino acids [17]. CERK is acting in the sig-
nal transduction cascade and is suggested to be involved
in the process of synaptic vehicle fusion [18]. KIAA0767
and KIAA1646 consist of 18 and 13 exons, respectively,
spanning each ~50 kb on genomic DNA.
Methods
We selected two affected individuals (933, 1045) from
different branches of F20, and two cases (727, 857) of
smaller pedigrees F15 and F17, which were compatible
with linkage to chromosome 22q [19], as well as DNA of
a healthy individual as control. In the association study
we included 115 unrelated cases with periodic catatonia
(66 males; mean age first hospitalisation: 26.2 years, SD
10.5; age at assessment: 44.6 years, SD 17.1) and 110
blood donors as controls (60 males; mean age at assess-
ment: 29.5 years, SD 9.4). All subjects actively partici-
pated in the study after giving informed consent. The
Ethics Committee of the University of Würzburg had
approved the study.
Primers covered in overlapping fragments parts of the 5'-
UTR containing putative promoter regions [20] and were
allocated in intronic regions to encompass the complete
exon and adjacent splice-junctions as well as parts of the
3'-UTR up to ~1.0 kb. PCR (30 sec at 94°C, 30 sec at 57°/
60°C, and 30 sec at 72°C for 32 cycles) was carried out in
25 µl reaction volumes containing ~80 ng genomic DNA,
20 pmol of each primer, 200 µM of each dNTP, 0.5 U Taq
DNA polymerase (Fermentas), and buffer as supplied by
the manufacturer in a MJ Research 96-well block Tetrad
thermocycler (Waltham, MA). Exon 1 of CERK was not
sequenced because of technical difficulties. PCR products
were purified by solid phase extraction and bidirectionally
sequenced with ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA) followed by
computer-assisted analyses. For restriction fragment anal-
yses (RFLP) PCR products were amplified on a Thermocy-
cler (Biometra, Göttingen), and subsequently digested
with the appropriate enzyme (CERK V338G: DraIII;
KIAA0767 S159I: MboI). Fragments were resolved on a
10% PAA gel containing 1.0 × TBE at 15 V/cm2 followed
by silverstaining.
Results
In the mutation screening sample we identified seven sin-
gle nucleotide polymorphisms (SNPs) at the KIAA0767/
DIP locus (Table 1). Nt 45379466 G>T changes a serine to
isoleucine (S159I). We identified case 857 as a heterozy-
gote carrier; the variant, however, did not co-segregate
with the disease in the multiplex pedigree. The SNP was
introduced through an unaffected individual, who mar-
ried into the family. In addition, we did not observe 159I
in a sample of 450 chromosomes (115 index cases withBMC Psychiatry 2005, 5:36 http://www.biomedcentral.com/1471-244X/5/36
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periodic catatonia and 110 controls, respectively). These
findings coincidently indicated that 159I is a rare variant,
but not associated with disease susceptibility.
The systematic scan of KIAA1646/CERK resulted in a total
of 17 SNPs (Table 2). We observed the coding variant
338G by sequencing DNA-amplicons of a control subject.
In a subsequent case-control association study, we found
a frequency of the heterozygous genotype of 0.9% (2 out
of 220 alleles) compared to a frequency of the hetero-
zygous genotype of 2.2% in periodic catatonia (5 out of
230 alleles; ns). In addition, the variants C50 and D377
were both non-segregating within the multiplex pedigree
F20, as did the synonymous N500 in the respective
pedigrees.
Eleven of the 24 SNPs had not yet been deposited in cur-
rent databases. At the CERK locus rs 2542014 was linked
to a nearby (+2 bp) variant at nt 45403531. The intronic
SNPs at nt 45415691C>G (KIAA1646) and nt 45392050
T>C (KIAA0767) were found at allelic frequencies useful
for further LD-mapping studies.
Discussion
Sustained interest in schizophrenia susceptibility on chro-
mosome 22q is substantiated by several genome-wide
linkage studies on schizophrenic psychoses [21-23].
Because of reports of schizophrenia susceptibility genes
within the 22q11 region, this locus has obtained a high
marker density compared to the 22q13 region [24].
Although only weak signals for linkage to chromosome
22q11 were received by recent multicenter and meta-ana-
lytic studies [25,26], subsets of pedigrees in the study by
Mowry et al. [25] gave positive scores for chromosome
22q13, particularly if accounting for intersample hetero-
geneity. The pedigrees analyzed here were not part of
these multicenter samples. We focused on the phenotype
periodic catatonia [[27]; #605419] with a major disease
locus at chromosome 15q15, and at least one further
independent locus at chromosome 22q13, mainly sup-
ported by a large four-generational pedigree [3]. As it has
been already demonstrated in several chromosome
15q15-linked pedigrees, haplotype analyses in pedigree
F20 showed autosomal dominant transmission [3,6]. The
lack of common haplotypes in unrelated families, how-
ever, added further evidence to genetic and allelic hetero-
geneity in periodic catatonia.
The chromosome 22qtel candidate locus of ~4 Mb com-
prises more than 45 genes [28], and harbours several
genes involved in severe neuropsychiatric disorders, such
as metachromatic leukodystrophy and megalencephalic
leukoencephalopathy [[27]: #250100; #604004]. In a sys-
tematic mutation scan of positional candidates at the
chromosome 22qtel candidate region we screened ~3400
nt of coding sequence including splice-donor sites and
additionally parts of the 5'-UTR and 3'-UTR of KIAA0767
and KIAA1646, respectively. The mutation scan revealed
24 sequence variants, among them two rare codon vari-
ants (KIAA0767: S159I; KIAA1646: V338G). However,
both neither were found to segregate with the disease in
the respective pedigrees nor found at a significant fre-
quency in periodic catatonia.
Human KIAA0767/DIP [GenBank: NM_015124;
LocusLink: 23151] consists of 18 exons, spanning ~50 kb
on genomic DNA [NT_011523.2]. KIAA0767 is a protein
of 578 amino acids (aa) putatively localized in the mito-
chondrion [16]. KIAA0767 expression resulted in a signif-
icant loss of cell viability independent of the p53 status,
and thus, termed death-inducing-protein (DIP) because
of its strong pro-apoptotic effect [16]. DIP shows at least
two transmembrane domains and multiple putative phos-
phorylation and glycolisation sites. The variant S159I,
Table 1: sequence variable at the KIAA0767/DIP locus on chromosome 22q13. 3
Nucleotide position * DNA level Nucleotide change Codon SNP-database Genotypes of the individuals from each family
933 1045 727 857 Ctrl Allele frequency
45377716 Intron 3 C>T - rs 2076708 CC CC CC CC CT C: 0.9 T: 0.1
45379466 Exon 5 G>T S1591 - GG GG GG GT GG G: 0.9 T: 0.1
45385184 Intron 11 C>T - - CT CC CC CC CT C: 0.8 T: 0.2
45385356 Intron 12 A>C - rs 2076711 AA AA AA AA AC A: 0.9 C: 0.1
45391987 Intron 16 C>T - - CC CC CC CC CT C: 0.9 T: 0.1
45392051 Intron 16 T>C - - TT TT TC TC TC T: 0.7 C: 0.3
45392996 Intron 16 G>A - rs 2236028 GA GG GG GG GA G: 0.8 A: 0.2
* nt position according the UCSC Genome Browser May 2004 assembly [14; NM\_022766].
Nucleotide changes found by automated sequencing of amplicons of four individuals from pedigrees segregating periodic catatonia evaluated in a 
genome-wide linkage scan [3, 19]: 933 and 1045 (F20), 727 and 857 (F15,F17), and a control subject.BMC Psychiatry 2005, 5:36 http://www.biomedcentral.com/1471-244X/5/36
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however, seems not to affect any of the various functional
DIP/KIAA0767 protein domains.
Human KIAA1646/CERK [GenBank: NM_022766;
LocusLink: 64781] consists of 13 exons, spanning ~50 kb
on genomic DNA. CERK is a cytoplasmatic and mem-
brane-associated protein of 537 amino acids with a calcu-
lated molecular weight of 60 kDa. It is a member of a new
class of lipid kinases and acts in the signal transduction
cascade of the control of apoptosis catalyzing specifically
the phosphorylation of ceramide [17]. The component
ceramide is thought to regulate apoptotic responses to
stress, particularly those initiated by the mitochondria.
CERK is highly expressed in brain and leukocytes, and is
suggested to be involved in synaptic neurotransmitter
release [18] or in phagocytosis and vehicle fusion in neu-
trophils and mast cells [17,29,30]. In CERK, the pleckstrin
homology domain and the diacylglycerol kinase (DGK)
catalytic domain were found non-polymorphic, but
V338G was located in the central homologous region,
near the casein kinase II phosphorylation site at S340, and
V338 is conserved between human and mouse CERK
[17,31]. Although V338G may be of functional relevance,
it was not found associated with periodic catatonia.
Recent reports that mutations in the related gene CERKL
on chromosome 2q31 cause autosomal recessive retinitis
pigmentosa (RP26) indicate a link of the ceramide kinase
gene family to retinal neurodegeneration [32].
Starting from linkage signals at chromosome22qtel in peri-
odic catatonia, we screened two positional brain-
expressed candidate genes for genetic variation
(KIAA0767/DIP; KIAA1646/CERK). Our study excludes
variants at coding and putative promoter regions as caus-
ative factors in periodic catatonia, but do not exclude the
involvement of other regulatory elements in intronic or
extended promoter regions. Although negative, the
present study narrowed down the putative susceptibility
region, and provides a systematic SNP generation for
forthcoming LD studies.
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